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Abstract
Cerebral palsy (CP) is an upper motor neuron disease that results in a spectrum of movement disorders. Secondary to the
neurological lesion, muscles from patients with CP are often spastic and form debilitating contractures that limit range of
motion and joint function. With no genetic component, the pathology of skeletal muscle in CP is a response to aberrant
complex neurological input in ways that are not fully understood. This study was designed to gain further understanding of
the skeletal muscle response in CP using transcriptional profiling correlated with functional measures to broadly investigate
muscle adaptations leading to mechanical deficits. Biospsies were obtained from both the gracilis and semitendinosus
muscles from a cohort of patients with CP (n = 10) and typically developing patients (n = 10) undergoing surgery. Biopsies
were obtained to define the unique expression profile of the contractures and passive mechanical testing was conducted to
determine stiffness values in previously published work. Affymetrix HG-U133A 2.0 chips (n = 40) generated expression data,
which was validated for selected transcripts using quantitative real-time PCR. Chips were clustered based on their
expression and those from patients with CP clustered separately. Significant genes were determined conservatively based
on the overlap of three summarization algorithms (n = 1,398). Significantly altered genes were analyzed for over-
representation among gene ontologies and muscle specific networks. The majority of altered transcripts were related to
increased extracellular matrix expression in CP and a decrease in metabolism and ubiquitin ligase activity. The increase in
extracellular matrix products was correlated with mechanical measures demonstrating the importance in disability. These
data lay a framework for further studies and development of novel therapies.
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Introduction
CP (CP) is a movement disorder caused by an upper motor
neuron (UMN) lesion in the developing brain [1]. There are a
range of prenatal, perinatal, and postnatal causes of CP and it is
often associated with periventricular leukomalacia [2]. CP covers a
spectrum of severities and is the most common childhood
movement disorder with a prevalence of 3.6 cases per 1000 in
the US that has not decreased with medical advances [3]. While
the UMN lesion that initiates CP is non-progressive, many
secondary changes occur within the musculoskeletal system that
are progressive and debilitating [4]. Among the hallmarks of CP is
muscle spasticity, in which the muscle contracts in a velocity
dependent resistance to stretch that results, in part, from reduced
inhibition of the stretch reflex [5]. While the disability that results
from spasticity is variable [6,7] patients with spastic CP may also
develop muscle contractures secondary to the lesion. Fixed muscle
contractures represent a unique muscle adaptation in which
muscles detrimentally limit the range of motion around a joint
without being activated. These muscle contractures limit mobility,
may be painful, and represent a major disability among those
affected by CP or anyone with an UMN lesion [8].
There are a variety of treatments designed to inhibit muscle
activity in CP and prevent contracture formation. Physical therapy
techniques, oral muscle relaxants, intrathecal placement of
medication (baclofen), chemical neurectomies with phenol or
alcohol, chemodenervation using neurotoxins, and surgical neu-
rectomies have all been employed to decrease spasticity in children
with CP [9]. However, despite best clinical practices, contractures
still develop and often require surgery to correct [10]. It should
also be noted that all of these therapies reduce muscle strength in a
condition in which strength is already compromised. Clearly
current therapies are not ideal.
There are no known genetic defects in patients with CP and
their muscles, as it is a direct consequence of the UMN lesion [11].
Although skeletal muscle is known to be highly adaptive in
response to neurological input, muscle contractures that develop
are part of an adaptive mechanism that is not fully understood.
Contracture does not develop in animal models of increased
muscle use, which could be present from decreased motor neuron
inhibition, or even decreased muscle use, which could result in
decreased functionality [4]. Indeed UMN contractures are not
readily reproducible in animal models, thus necessitating research
on human subjects [12]. The underlying transcriptional alterations
have important consequences in the development of increased
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passive mechanical properties and pathologic contracture. Under-
standing the precise nature of transcripts differential regulation
can delineate the mechanisms that accompany contracture,
including but not limited to increased passive tension.
Previous research demonstrated that muscle stiffness in
contracture is independent of active muscle contraction [13,14].
Recent mechanical measurements of biopsies from pediatric
hamstring muscles indicate that the increased muscle stiffness is
due to alterations in extracellular matrix (ECM) rather than the
stiffness of muscle fibers themselves [15]. Multiple studies have also
shown an increase in sarcomere length of muscle in contracture,
demonstrating contractured muscle experiences high intrinsic
strain [16] due to dramatic, but unknown structural alterations.
These results suggests a decrease in the serial sarcomere number
despite conflicting evidence as to whether muscle fascicle length
decreases [17–20]. Studies have shown that muscle and muscle
fiber cross sectional area are reduced, which decreases force
production, and even that the remaining muscle has decreased
force generating capacity [21–23]. These mechanical and
architectural changes in muscle implicate a disruption of the
biological components involved in myogenesis, force generation,
force transmission, extracellular matrix maintenance, and perhaps
additional pathways. Recent microarray data from the upper
extremity supports the assertion that CP muscle is altered
transcriptionally and that in addition to the pathways listed above,
neuromuscular junction activity, excitation-contraction coupling,
and energy metabolism are also deranged [24].
As a purely adaptive muscle disorder, contractures are believed
to have an altered transcriptional profile. The current study has
taken advantage of a large surgical population of both children
with CP and typically developing children to conduct a robust
microarray analysis correlated to mechanical parameters. Our
previous study was limited by a very small control subject
population which was not age matched, (N= 2) [24], and
microarray studies in humans subjects generally require larger
sample sizes to identify differences due to the higher variability
present in human tissues compared to most inbred animal strains.
Additionally the same biopsies reported here have been used to
collect mechanical data that was recently published, allowing the
comparison of our transcriptional data to functional parameters
[15]. We also took advantage of recent additions of muscle specific
gene ontologies and muscle specific gene networks to probe the
muscle and compare the pathology to microarrays from other
published muscle conditions ([25]; Smith et al. in press). A
mechanistic understanding of muscle adaptation to contracture
may lead to discovery of possible therapeutic targets that can delay
or even reverse the debilitating effects of CP or other UMN
lesions.
Results
For this transcriptional study, a cohort of 20 subjects were
recruited. 10 patients with cerebral palsy were undergoing
hamstring lengthening surgery, making biopsies of gracilis and
semitendinosus accessible. The disease parameters of these
subjects are listed in Table 1. Gracilis and semitendinosus are
synergistic muscles that both create a knee flexion moment, and
thus their surgical release facilitates knee extension. Surgery is
required because both muscles studied are in the state of
pathologic muscle contracture. As control subjects, 10 typically
developing pediatric patients who were approximately age
matched were included, who were undergoing ACL reconstruc-
tion surgery with a hamstring autograft that made gracilis and
semitendinosus muscles accessible. A separate microarray was
used for each muscle biopsy, resulting in a total of 40 microarrays.
Significantly altered genes
Among the 22,283 probesets on the microarray, 13,787 were
considered present for further analysis. Of those 1,398 genes were
identified as significantly different in CP (2,836 for Microarray
Suite Version 5.0 (MAS5), 3,954 for Robust Multiarray Analysis
(RMA), and 4,009 for GC-RMA; Table S1). Of these genes, 533
had expression increased in CP while 865 genes had expression
decreased. The 262 ANOVA yielded only 3 genes (MAB21L1,
SIM1, and EN1) with unknown roles in muscle as significantly
different between muscles, demonstrating that both muscles have
similar expression profiles. There were also no genes that
produced a significant interaction between muscle type and
disease state, indicating that both muscles undergo similar changes
in CP.
Table 1. Subject parameters.
Cerebral Palsy Subjects Typically Developing Subjects
Subject ID Sex Age (years) Region GMFCS Popliteal Angle Subject ID Sex Age (years)
8 M 16 Q V 90 1 M 14
9 M 11 H II 110 2 F 16
30 M 4 D II 125 5 F 13
32 F 8 D II 95 6 F 15
34 M 15 D II 120 10 M 15
35 M 6 Q V 130 12 M 16
37 M 9 H II 95 18 F 17
38 M 9 D II 100 28 M 15
39 M 15 D II 120 31 M 14
40 M 10 D II 120 33 M 13
The parameters for each subject is specified. Region indicates the regions of the body effected: (Q) quadriplegic, (H) hemiplegic, and (D) Diplegic. Gross Motor Function
Classification System (GMFCS) score is a functional parameter ranging from I (least severe) to V (most severe). Popliteal angle is a measure of knee extension and
represents the maximum angle of the upper leg to lower leg when the hip is flexed at 90u.
doi:10.1371/journal.pone.0040686.t001
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Condition tree clustering
The condition tree was conducted based on all present genes on
the microarray and resulted in a clustering of CP subject biopsies
distinct from typically developing subject biopsies, with the
exception of one mild CP subject (Figure 1). The condition tree
also shows that biopsies from the two muscles of the same patient
cluster together. This result indicates that the two hamstring
muscles, gracilis and semitendinosus, have less variability within a
subject than the variability between subjects with the same
condition. With a large sample size there was an expectation that
biopsies from patients with similar clinical severity scores would
cluster together. This trend was not observed in the data.
Quantitative Real Time PCR
As a quality control measure, qRT-PCR was performed on a
subset of relevant genes, 2 significantly up-regulated, 2 not
significantly altered, 2 significantly down regulated, and 2 genes of
interest not present on the microarray. We chose these represen-
tative genes since they are commonly studied in muscle physiology.
Comparison of qRT-PCR to microarray datasets revealed a
significant correlation (p,0.05) in all 6 genes examined
(Figure 2A–F). qRT-PCR was also conducted on 2 genes of
interest involved in the muscle atrophic process that do not have
corresponding probesets on the microarray that had expression
ratios of (0.48) TRIM63 and (0.79) FBXO32. TRIM63 expression
had a significant main effect of CP (p,0.01) (Figure 2G–H).
Categorical analysis
Secondary analysis was performed using predefined gene sets
for Gene Ontology allowing the categorization of significantly
altered genes in CP. There were 87 gene ontologies over-
represented from the list of significantly genes up-regulated in
Figure 1. Condition tree from Pearson correlation clustering algorithm. Individual genes are colored according to expression ratio. CP
samples cluster separately from typically developing controls, except for one subject. Both subject sample being clustered together indicates
relatively little variability between gracilis and semitendinosus biopsies from the same subject. Table contains Subject ID in row 1 and either typically
developing (TD) or CP (CP) in row 2.
doi:10.1371/journal.pone.0040686.g001
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Figure 2. Comparison of quantitative real-time PCR data to microarray data. The microarray data from MAS5 summarization algorithm is
used. Each gene in A–F has a significant correlation (p,0.05). (G) atrogin-1 (FBXO32) and (H) MURF-1 (TRIM63) are quantified based on disease state
and muscle as they are not present on the microarray.
doi:10.1371/journal.pone.0040686.g002
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CP (Table S2, Table 2). Of note are a large portion of extracellular
matrix ontologies as well as those for calcium ion binding and
cytoskeleton ontologies. Categories discussed are presented in
Table 2. Among genes that were down-regulated in CP, 85
ontologies were significantly over-represented (Table S2, Table 2).
These ontologies primarily fell into the categories of metabolic
processes and ubiquitin related pathways and also interestingly
included skeletal muscle contraction.
Network analysis
We recently created networks of genes related to muscle
function to enable detailed investigation of muscle-specific gene
expression. A heatmap, using expression ratios, is created with
genes listed in their 9 respective functions with genes in those
determined as significantly different in CP according to previous
analysis (Figure 3). Some genes appear in multiple functions and
some genes are listed within gene complexes (Table S3).
Most of the networks had a selection of genes that were both up
and down regulated in CP. These include: the neuromuscular
junction, excitation contraction coupling, cytoskeleton elements,
and muscle signaling. Other networks had transcripts that were
altered in a more uniform manner. Most strikingly, the
extracellular matrix had 14 out of 20 transcripts with increased
transcription. On the other hand muscle metabolic factors had 11
out of 37 transcripts down regulated and only one up regulated.
Unfortunately only 7 of the inflammatory markers were present
and available for analysis on the microarray. Some proteins
function with a different isoform in fast or slow muscle that is
transcribed from a separate gene. There was no significant change
in expression among the slow isoforms, however 5 out of the 11
transcripts for fast isoforms were significantly down regulated. This
indicates a relative shift to slow fibers that corresponds to the
myosin heavy chain protein content of the muscles [15].
mRNA correlations to passive stiffness
A unique aspect of this study was the corresponding mechanical
measurements from the same muscle biopsies in 17 of the 20
subjects. Individual fibers were isolated and mechanically tested to
determine stiffness [15]. Fiber bundles, consisting of a group of
approximately 20 fibers and their constituent extracellular matrix,
were tested in the same way. Mechanical stiffness for fibers and
fiber bundles was correlated with each of the significant genes in
CP. 27 genes had a significant (p,0.05) positive correlation with
fiber stiffness and 50 genes had a significant negative correlation
(Table 3A, 3B; Figure 4; Table S4). These gene lists were used for
categorical gene ontology analysis with the total significantly
altered in CP gene list as the reference set to determine which
categories were over-represented (Table S5). From the genes
positively correlated with fiber stiffness there were no categories
significantly up-regulated. However among the negatively corre-
lated genes, 29 ontologies were significantly (p,0.05) over-
represented, with most ontologies related to ubiquitin ligase
Table 2. Highlighted gene ontologies significantly over-represented in genes significantly altered in CP.
Gene Ontology GO# Category Observed Expected p-value
Biological Process Increased in CP
extracellular matrix organization 0030198 86 20 3.57 1.55e-07
collagen metabolic process 0032963 38 8 1.58 0.0044
actin cytoskeleton organization 0030036 213 22 8.85 0.0044
Molecular Function
calcium ion binding 0005509 680 64 28.22 3.91e-08
collagen binding 0005518 32 8 1.33 0.0005
growth factor binding 0019838 97 14 4.02 0.0006
Cellular Component
collagen 0005581 31 12 1.31 4.60e-08
cytoskeleton 0005856 1008 75 42.73 1.58e-05
basal lamina 0005605 15 6 0.64 0.0003
Biological Process Decreased in CP
ubiquitin-dependent protein catabolic process 0006511 190 33 12.18 9.76e-06
glucose metabolic process 0006006 116 19 7.43 0.0041
skeletal muscle contraction 0003009 15 6 0.96 0.0073
Molecular Function
ligase activity 0016874 281 43 18.12 6.48e-06
ubiquitin-protein ligase activity 0004842 107 23 6.90 1.39e-05
zinc ion binding 0008270 1447 128 93.32 0.0028
Cellular Component
proteasome complex 0000502 54 11 3.35 0.0047
cis-Golgi network 0005801 12 5 0.74 0.0056
nuclear lumen 0031981 1203 101 74.65 0.0081
(Category) is the number of genes on the reference list or in this case on the microarray that fall under the ontology. (Observed) is the number of genes on either the
significantly up or down-regulated in CP list. (Expected) is the number of genes expected to be in the significantly altered list based on the relative sizes of lists.
doi:10.1371/journal.pone.0040686.t002
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activity. This suggests that when genes in the ubiquitin protease
system are most active muscle fibers lose mechanical stiffness.
When fiber bundle mechanics are considered, 141 genes had a
positive and 95 genes a negative significant correlations with
stiffness values (Table 3C, 3D). There were 36 ontologies
significantly over-represented with a positive correlation to bundle
stiffness. These consisted almost exclusively of ontologies related to
the extracellular matrix, indicating the matrix plays an important
role in the stiffness of fiber bundles. Only 2 ontologies were
significantly over-represented among genes negatively correlated
with bundle stiffness. Those related to mitochondrial structure,
suggesting a relationship between muscle stiffness and energy
production.
Figure 3. Heatmap of functional muscle gene networks. Heatmap based on expression ratio and separated by Entrez gene symbols are used
for individual entities with the exception of gene families found in Table S3 in which case geometric means of multiple genes determine expression
ratio. Gene symbols found to be significantly different in CP are colored based on direction of regulation. Gene families are colored if any individual
gene in the family is significantly altered in CP. Genes with N/A were either not present on the chip or did not have expression to qualify as present in
analysis.
doi:10.1371/journal.pone.0040686.g003
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Discussion
The objective of this study was to describe the transcriptional
adaptations that occur in skeletal muscle of patients with CP and
incorporate functional data to determine the cellular mechanisms
that drive the muscle pathology secondary to the upper motor
neuron lesion. This research has seen little prior work, as there is
no commonly accepted animal model necessitating the challenges
of direct human research [12]. Without any genetic defect in the
muscle, it is clear that the pathology has a large transcriptional
component across many genes (Figure 1). The large number of
altered transcripts fall into a variety of gene ontologies and
biological pathways, as well as important functional networks
within skeletal muscle. Some of these vital muscle systems such as
the extracellular matrix have a correlation between transcript
levels and tissue stiffness.
The condition tree clustering demonstrates the difference
between the transcriptional profile of muscles from patients with
CP or typically developing (Figure 1). This separation was nearly
100% as only a single CP patient clustered more closely with the
controls. It should be noted that this was one of the more mild
Figure 4. Correlation between transcript levels and stiffness. Examples of significant correlation (p,0.05) between mRNA expression levels
and passive mechanical stiffness measurements. (A) ubiquitin-conjugating enzyme E2I (UBE2I) has a negative correlation with fiber stiffness. (B)
Collagen XXI alpha I (COL21A1) has a positive correlation with fiber bundle stiffness. (C) adenylate kinase 2 (AK2) and a mitochondrial intermembrane
transcript has a negative correlation with bundle stiffness.
doi:10.1371/journal.pone.0040686.g004
Table 3. Gene ontology of transcripts correlated with stiffness.
Gene Ontology Observed Expected p-value
Biological Process (selection from 21) Positive Bundle Stiffness Correlation
extracellular matrix organization 13 2.25 5.54E-06
collagen fibril organization 8 1.07 7.53E-05
collagen biosynthetic process 5 0.54 1.40E-03
Molecular Function (selection from 5)
extracellular matrix structural constituent 12 2.25 2.58E-05
growth factor binding 8 2.25 2.56E-02
proteoglycan binding 3 0.32 2.60E-02
Cellular Component (selection from 10)
proteinaceous extracellular matrix 22 5.46 1.65E-07
fibrillar collagen 6 0.75 2.00E-04
basement membrane 8 1.93 4.70E-03
Cellular Component Negative Bundle Stiffness Correlation
mitochondrial intermembrane space 4 0.36 6.70E-03
organelle envelope lumen 4 0.43 1.00E-02
Biological Process (selection from 20) Negative Fiber Stiffness Correlation
ubiquitin-dependent protein catabolic process 7 1.34 2.54E-02
cellular protein catabolic process 9 2.89 3.18E-02
proteasomal protein catabolic process 4 0.60 3.81E-02
Cellular Component (selection from 9)
nucleus 28 16.61 1.44E-02
proteasome complex 4 0.48 2.16E-02
membrane-bounded organelle 35 25.73 2.76E-02
Gene ontologies that were over-represented among genes that had a significant correlation (p,0.05) with either fiber or fiber bundle passive stiffness measurements.
(Category) is the number of genes on the reference list or in this case significantly altered in CP. (Observed) is the number of genes significantly correlated with
mechanical stiffness that fall into the category. (Expected) is the number of genes expected to be in the significantly altered list based on the relative sizes of lists.
doi:10.1371/journal.pone.0040686.t003
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cases of CP and the highest popliteal angle of the entire group
(120u, least amount of contracture). The clustering algorithm did
not, however, group the CP muscle by the clinical severity scores,
age, or even muscle. The patients themselves had both biopsies
clustered together consistently indicated that the variation from
subject to subject is higher than that between muscles of the same
subject. This finding was described in a previous study using
multiple muscles from a single subject [24].
Categorical analysis
To determine the various functions that are altered in CP we
first established a list of genes with altered transcription. We
sought to narrow our results by using a more stringent analysis that
uses the congruence of three summarization algorithms as well as a
restrictive false discovery rate of 1%. This still produced a large
gene list due to the large sample size, but we chose not to
implement a fold change cutoff as this assumes an arbitrary level of
change is required to be functionally important [26]. We used
categorical analysis to determine altered functional gene categories
in CP.
Among the up-regulated transcripts there were a total of 87
gene ontologies over-represented, but they generally fell into only
a few categories. The increase in extracellular matrix transcripts
has been well documented in muscle from CP [24,27,28].
However the structure of the extracellular matrix increases is not
well known. This study shows how extensive the increase in
extracellular matrix is with categories ranging from fibrillar
collagen, basal lamina and even collagen metabolic process.
Increased structural categories continue through the cell with
ontologies including integrin binding, cytoskeletal binding protein,
and cytoskeleton. This could have an effect on individual fiber
stiffness, but the stiffness of fibers in CP is inconsistent [15,29].
There were ontologies important in muscle function that had over-
representation as well with calcium ion binding. A disruption of
calcium handling had been suggested previously, where PARV was
drastically altered in CP muscle [24], however here PARV was
unchanged. The impact of growth factor binding is also crucial in
skeletal muscle, with many of the transcripts being IGF binding
proteins known to be important in skeletal muscle.
Contrastingly, there were 62 ontologies that were over-
represented in down-regulated genes. The most extensive of these
were related to metabolic processes and ubiquitin ligases. Skeletal
muscle is a very metabolically active tissue and these results suggest
that, despite spasticity, the muscle has less metabolic machinery.
This decrease was also seen in the previous transcriptional study in
CP, however this was accompanied by a shift to faster fiber types,
which was not the case here [24]. The ubiquitin ligase role is
surprising here as it is generally accepted that muscle in CP has
decreased mass [21,30]. This result suggests that decreased muscle
mass is not due to active muscle degradation. The obvious
importance of the skeletal muscle contraction ontology is also
represented. Together these results imply that muscle protein
turnover is decreased in CP.
Network analysis
Categorical analysis provides an avenue to analyze vast gene
lists into manageable pieces. However, we also sought to
investigate more deeply into networks of genes critical to muscle
function using a recently established gene networks (Smith et al., in
press). As CP is neurological in origin, the neuromuscular junction
could be altered and has indeed been shown to have a
disorganized nature in CP [31]. The results did not show
overwhelming changes in the neuromuscular junction, the
acetylcholine receptor (CHRN) was down-regulated. CHRN is
dramatically up-regulated when muscle is denervated [32], which
our results clearly show is not the case in CP muscle. Most of the
changes were associated with extracellular matrix proteins
localized to the neuromuscular junction. However, unlike the
majority of extracellular matrix transcripts COL4 was down-
regulated as was UTRN an important link to the extracellular
matrix of the neuromuscular junction. It is unclear how these
adaptations change the function of the neuromuscular junction,
but it does support evidence for disorganization [31].
Excitation-contraction coupling has been largely unexplored in
CP, but has been shown to be altered and is also the target of
therapeutic intervention [24,33]. The transcripts altered in this
study were unique however, and primarily down-regulated in CP.
Genes such as ASPH and DHPR which have a role in activating the
-ryanodine receptor are down-regulated. As are mechanisms for
pumping calcium back in to the sarcoplasmic reticulum with
ATP2A and its regulator SLN. Further, a decrease in transcripts of
calcium binding proteins of CALM1 and downstream CAMK2
suggest that there is less calcium cycling in CP muscle. The only
up-regulated transcript was RYR3, which is a ryanodine receptor
expressed in immature muscle, and reinforces the theme that there
are a number of immature transcripts in these muscles.
That theme is also observed in the contractile transcripts of
skeletal muscle. The only up-regulated genes are immature
isoforms embryonic myosin heavy chain (MYH3) and embryonic
myosin light chain (MYL4). Many of the contractile elements have
well defined isoforms that have genes expressed in either fast or
slow muscle [34]. Many of the down-regulated transcripts are
isoforms of the fast isoforms, which will be discussed with respect
to fiber type. Interestingly, both thin filament Z-disc capping
protein CAPZ and titin filament Z-disc capping protein TCAP are
down-regulated in CP. This could lead to Z-disc disorganization
and TCAP itself is associated with destabilization in limb girdle
muscular dystrophy 2G [35].
The force generated in the sarcomere is transmitted through the
cytoskeleton to the cell periphery, but the effects in CP have been
largely unexplored. Our results are somewhat difficult to interpret
with many genes both up and down-regulated. Of those associated
with the dystroglycan complex, sarcoglycans (SGC) and snytro-
phins (SNT) as well as UTRN are down-regulated. This is while
many crosslinking transcripts of the cytoskeleton are up-regulated
(ankyrin (ANK), sprectrin (SPT), filamin (FLNC)) along with an
important connector to the Z-disc (MYOZ2). What role these
increased cytoskeletal filament connections may play is unknown,
but they did not lead to increased fiber stiffness [15]. The
cytoskeletal connection to the nucleus is interesting as EMD and
LMNA, which both lead to Dreifuss-Emery muscular dystrophy
when absent are not co-regulated with EMD decreased and LMNA
increased [36,37]. One aspect that is consistent is that VIM is up-
regulated, which is the primary immature muscle intermediate
filament that is replaced with desmin (DES) during development.
The force generated in the cell is ultimately transferred to the
extracellular matrix, which is significantly altered in various
analyses here as well as numerous other studies of CP [24,27,28].
This alteration is nearly uniformly up-regulated, with the
exception of the COL4 isoforms in the neuromuscular junction
previously described. It is important to note that the increase
includes many categories, fibrillar collagens, laminar collagens,
proteoglycans, matrix metalloproteinases, matrix metalloprotei-
nase inhibitors, and extracellular matrix growth factors. This
uniform increase does not permit speculation on how the
extracellular matrix may be prolific, yet disorganized as speculated
in CP muscle [28]. With all the increase in extracellular matrix
components it would be expected that TGFB1, an important
Muscle Transcript Abnormalities in Cerebral Palsy
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fibrosis signal in muscle, would be increased [38]. Although it did
have higher expression in CP it was not significant and shows that
ECM alterations can occur independent of a large TGFB1
autocrine increase and may be more closely tied to TGFb
activation locally.
Another network with broad regulation was metabolic tran-
scripts, which were down-regulated in CP. This was observed in
gene ontologies, pathways, as well as previous studies [24]. The
fold change values on many of the transcripts were relatively low.
It should be noted that this change occurred despite a decrease in
fast muscle isoforms that have fewer mitochondria present. The
only increased transcript was LPL associated with fat metabolism
that is more prevalent in slow muscle. Despite an increase in non-
voluntary muscle contractions associated with spasticity [39], the
muscle is not producing more metabolic machinery. This could be
a result of the muscle being in the state of contracture and thus
have decreased functionality which contributes to disuse [40].
While the state of damage within a static muscle contracture is
relatively unknown, it is known that inflammation is present within
damaged muscle [41]. Wound healing and inflammatory path-
ways were up-regulated in categorical analysis, but unfortunately
few inflammatory transcripts were able to be analyzed in this
study. Of those that were altered were p38 (MAPK14) and a heat-
shock transcription factor (HSF2). The role of muscle damage in
pathologic CP muscle is not discernable from these data.
The critical aspect of muscle growth is a complicated system of
many genes and viewed the lack of muscle growth is considered
the primary cause of contracture [42–44]. However there are
many transcripts altered to induce muscle growth including down-
regulation of myostatin (MSTN) a critical muscle growth inhibitor,
its receptor (ACVR2B), and up-regulation of natural inhibitor
(FST). FGF2 also plays a role in stimulating muscle growth and
differentiation [45]. The muscle atrogene program is also
decreased with a drop in MURF1 (TRIM63) and its transcription
factor FOXO [46]. This MSTN signal is in contrast to the previous
study in CP muscle and is a candidate for being responsible for
blocking the growth signal in these muscles. The question of what
limits muscle growth in CP is not apparent from these results.
The role of fiber type has been discussed in regard to multiple
networks. The results here show clearly that while slow isoform
levels remain unchanged many fast isoforms have significant
decreases in transcription. The role of fiber type in upper motor
neuron lesions has been inconsistent [47,48], but these results
imply a proportional shift to slower muscle. This can be important
functionally, but is also very important in terms of a transcriptional
study. Many of the changes observed could be the result in
transcriptional changes from fast to slow muscle, such as the
decrease in glycolytic transcripts. However it is clear that the
pathology of muscle in CP is not purely a secondary effect of a shift
in fiber type.
mRNA correlations to passive stiffness
Having mechanical stiffness measurements for both the muscle
fibers and the muscle fiber bundles with their extracellular matrix
was a unique aspect of this study. There is literature to support the
role of the giant protein titin (TTN) in being the major contributor
to passive tension of individual fibers [49]. When considering the
muscle bundle much of the passive stiffness is believed to arise
from collagen, especially at larger sarcomere lengths [50].
Certainly many transcriptional factors could contribute to the
production of these important proteins or other proteins that have
a direct impact on the passive mechanical stiffness. Indeed 77
genes were correlated with fiber stiffness and 236 with bundles
stiffness. To determine the fundamental nature of these transcripts
we again used categorical analysis. It should be noted that since
only significantly altered genes were considered that was the gene
set used as a reference set, meaning correlated genes had to be
enriched beyond the significant gene list be over-represented.
For individual fiber there were actually no ontologies that had a
significant positive correlation with stiffness. However many
ontologies were associated with decreasing fiber stiffness, the vast
majority of which were related to ubiquitin ligases. This supports
the idea that as ubiquitin ligases become active and begin
degrading the muscle filaments, particularly titin, causing a loss of
passive stiffness [51].
When bundle stiffness is considered there are many more
ontologies over-represented (Table 3). Fittingly the most prevalent
ontologies are related to extracellular matrix, however there are
many more transcripts than fibrillar collagens thought to provide
the passive stiffness to bundles [52]. For example one of the most
highly correlated genes was COL21A1, which is a fibril associated
collagen that is found with collagen I and serves to maintain the
integrity of the extracellular matrix. This illustrates the complex
nature and the many factors that lead to tissue stiffness and that
could be contributing to fibrosis in CP. Additional ontologies were
over-represented including immune system process. This is an
indicator of damage in bundles that are stiffer and supports the
claim that muscle tissue damage leads to fibrosis in CP. Conversely
there were only two ontologies negatively correlated to bundle
stiffness, related to mitochondria. It is difficult to speculate in too
much detail from this small data set, but this suggests that more
metabolically active tissue, with increased mitochondria, is more
compliant. Perhaps this is simply a secondary effect of decreased
area fraction in myofilaments occupied by mitochondria.
Comparison to upper extremity
This study is similar to one conducted in the upper extremity of
muscle from patients with CP [24]. There are some important
differences in that the current study has a much larger sample size,
especially in terms of controls (10 in this study compared to 2 in
the previous). Additionally the typically developing control subjects
in the current study were injured months prior to surgery and thus
did not have recent acute trauma as a confounding factor.
Regardless, we expected to see many similar results between the
two studies. However this was not the case with only 19 genes
significantly altered in the same direction between the two studies
(Table S6). A possible explanation for this is the change in fiber
type, which was opposite in the studies, was driving many of the
transcriptional changes. Fast fibers have a more extensive calcium
cycling apparatus thus offering an explanation other than a
disruption of typical calcium handling in CP [24]. It is still
important to look at the similarities between the studies. The
obvious similarity is an increase in extracellular matrix in both
upper and lower extremity contracture, shown with ontology
analysis of genes altered in both studies. This is important in
placing fibrosis as a consistent property of muscle contractures in
CP. It should also be noted that both studies had an increase in
genes related to immature muscle, another possible hallmark of
muscle in a contractured state.
Implications
Despite CP being a spectrum disorder that is non-homogenous
in our subjects there are many common attributes [53]. This study
is valuable in highlighting many functions of skeletal muscle that
are disrupted in contractures caused by CP and detailing the gene
transcripts involved. It does not directly answer which programs
are inducing contracture or contributing to the lack of muscle
growth. However the most dramatic changes were seen in the
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drastic increases in extracellular matrix, which could blunt the
intracellular growth signals observed. Indeed it has been shown
that the extracellular stiffness can modulate skeletal muscle satellite
cells proliferation and differentiation [54,55]. Further matrix
digestion has been shown to have a positive effect on muscle
growth through satellite cell activation [56]. Combining previous
knowledge with this study establishes the extracellular matrix as a
novel treatment target for CP.
Summary
Skeletal muscle undergoes significant transcriptional alterations
secondary to upper motor neuron lesion in CP in which we have
identified many transcripts. These genes fall into several ontologies
with increases extracellular matrix components along with
decreases in metabolic, and muscle degradation systems. Muscle
specific network analysis recapitulates the increase in extracellular
matrix components along with an increase in muscle molecules
signaling for muscle growth. These are overlaid on a decrease in
fast muscle isoform transcripts and an increase in immature
muscle isoforms. The increases in extracellular matrix were seen to
be associated with an increase in the passive stiffness of the muscle
tissue and one of the few components consistent with previous
transcriptional studies into CP muscle. This work will assist future




Ethical approval for this study conformed to the standards of the
Declaration of Helsinki and was approved by the Institutional
Review Board at the University of California, San Diego Human
Research Protection Program. Age appropriate assent from the
patient as well as consent of the parent or guardian was obtained.
After obtaining consent, subjects with spastic CP (n = 10) were
recruited into the study based on undergoing distal hamstring
lengthening surgery involving both the gracilis and semitendinosus
muscles such that 2 muscle biopsies could be acquired per subject.
‘‘Control’’ subjects (n = 10) were pediatric patients undergoing
ACL (anterior cruciate ligament) reconstructive surgery of the
knee with hamstring autograft using gracilis and semitendinosus
tendons that were excised along with a distal portion of the muscle
that was obtained prior to trimming of the tendon. Control
patients did not have any neuromuscular disorders and were
ambulatory prior to surgery suggesting no damage to the
hamstring muscle from the injury. Their index injury occurred
at least 6 weeks before their surgery. However, because they were
having surgery to repair a torn ligament we acknowledge that
these are not truly normal muscles. However, given the ethical
constraints associated with taking muscle biopsies, we believe that
this is the best possible comparison group that can be envisioned.
Patients with CP had developed a fixed contracture requiring
surgery and were classified based on the clinical measures of Gross
Motor Function Classification System [57], popliteal angle, and
limb(s) affected. Patients had not received any neurotoxin injection
or previous surgical lengthening within the 2 years prior to
surgery. All muscle biopsies (n = 40) were snap frozen in liquid
nitrogen (2159uC) within ,1 minute of excision and stored at
280uC.
RNA extraction
RNA was extracted using a combination of standard Trizol
(Invitrogen, Carlsbad, CA) and RNeasy (Qiagen, Valencia, CA)
protocols. Briefly, approximately 30 mg of frozen muscle tissue
was homogenized using approximately 50 mg of RNase free
0.5 mm zirconium oxide beads (Next Advance, Averill Park, NY)
in 0.5 ml Trizol using a Bullet Blender (Next Advance, Averill
Park, NY). 0.1 ml of chloroform was added to the solution, then
vigorously vortexed for 15 seconds, then centrifuged at 4uC for
15 min. The upper aqueous layer was removed and mixed with an
equal volume of 70% ethanol before being added to the RNeasy
spin column. The column was washed and then incubated with
RNAse-free DNAse (Qiagen) for 15 minutes and then washed
again three times prior being eluted as described in the
manufacturer’s protocol. RNA concentration was determined by
absorbance at 260 nm, and the 260 nm-to-280 nm absorbance
ratios were calculated to define RNA purity.
Microarray processing
Affymetrix microarrays (HG-U133A 2.0; Affymetrix, Santa
Clara, CA) were used for each individual muscle biopsy (n = 40
chips). RNA processing including cDNA synthesis, cDNA labeling,
microarray hybridization, microarray scanning, and stringent
quality control measures were performed by the Gene Chip Core
at the Department of Veterans Affairs San Diego Health Care
System, (San Diego, CA). The raw data are available (.cel files) at
the Gene Expression Omnibus (GEO) under accession number
GSE31243.
Quantitative real time PCR
Quantitative real-time PCR (qRT-PCR) was conducted to
validate the expression levels of select genes (DMD, COL1A2,
MSTN, IGF1, COL4A2, and MYH1) and also to provide expression
values for two transcripts of interest not present on the microarray
(FBXO32 and TRIM63). The same RNA extracted for microarray
analysis was used for qRT-PCR. Isolated RNA was diluted 1:5
with DNase/RNase free water (Invitrogen) and 1 ml of each
sample was reverse transcribed using standard protocols (Super-
script III; Invitrogen). cDNA was amplified with the Cepheid
SmartCycle (Sunnyvale, CA) with primers designed specific to
each gene of interest (Table S7) using nBLAST and Oligo (version
6.6; Molecular Biology Insights, Cascade, CO). Each sample was
run in triplicate along a standard curve. The PCR reaction tube
contained 16PCR buffer, 2 mM MgCl2 (Invitrogen), 0.2 mM
sense and antisense primers, 0.2 mM dNTP, 0.26SYBR green,
and 1 U of platinum Taq polymerase (Invitrogen). Amplification
conditions included an initial hold at 95uC for 2 minutes with 40
cycles of denaturing at 95uC for 15 seconds, followed by annealing
and extension phases adjusted for each transcript. Success of each
the reaction was determined based on observation of a single
reaction product on an agarose gel and a single peak on the DNA
melting temperature curve determined after the 40 cycles. The
results of qRT-PCR were expressed using a standard curve
method with the ‘‘cycles to threshold’’ values represented the
number of PCR cycles at which the SYBR green signal was
increased above threshold. The triplicate measures were normal-
ized to the housekeeping gene GAPDH and then averaged. qRT-
PCR data were normalized to the median value of the gene to
facilitate comparisons to microarray data.
Microarray analysis
Data files were processed with GeneSpring Software (version
11.5.1; Agilent Software, Santa Clara, CA) for determination of
significantly altered genes and clustering analysis. Present genes
were determined from the MAS5 (Affymetrix) probe set algorithm
based on a 12.5% (5/40) present call. Each sample was clustered
based on MAS5 for present genes based on Pearson Correlation
similarity score and average linkage clustering algorithm.
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To provide a conservative choice of significantly altered genes in
CP, three independent probe set algorithms were used: MAS5,
RMA, and GCRMA. Requiring concordance among different
probe set algorithms has recently been used as an approach to
reduce false positives in data sets specific to any individual
algorithm. Each probe set was normalized to the median of the
microarray and then to the median of that probe set on all chips.
The probe set data were then condensed into gene level data in
GeneSpring by calculating the median value of all probe sets
belonging to a single gene. Gene values were analyzed by 262
Welch ANOVA based on pathology (CP vs. Control) and muscle
(gracilis vs. semitendinosus) with a Benjamini and Hochberg False
Discovery Rate for multiple testing correction setting the required
statistical significance to (p,0.01). For each algorithm significant
genes were separated into lists for increased or decreased
expression with CP, so that concordances of significant genes
were all in the same direction.Accordingly, 1% of the genes
deemed significant for an individual probeset algorithm are
suspected to be false positives and genes that passed in all three
algorithms were designated as significantly different for further
analysis.
Microarray categorical analysis
After the significantly altered genes were defined, categorical
analysis was used to provide information on over represented
subsets of genes. Enrichment analysis was performed on up-
regulated and down-regulated genes independently with Web-
Gausalt (http://bioinfo.vanderbilt.edu/webgestalt/) on Gene On-
tology, KEGG Pathways, transcription factor targets, and
microRNA targets [58,59]. The hypergeometric statistical method
was used with a Benjiman-Hochberg multiple testing correction
with a significance level of (p,0.01) requiring a minimum of 3
genes per category.
Network analysis was also conducted to determine the
proportion of significantly altered genes present in a recently-
published muscle gene network (L. Smith, G. Meyer, and R.
Lieber, submitted). As these networks are specific to skeletal
muscle function, each gene in the network was also investigated in
order to avoid arbitrary cutoffs. The networks were visualized
using Cytoscape (Version 2.8.1; Cytoscape Consortium) [60] and
the nodes colored based on expression level defined as the average
expression in CP:average expression of controls. For complexes,
the geometric mean of expression ratios is reported and
significance is denoted if at least one gene in the complex was
significantly different.
mRNA correlations to passive stiffness
The same biopsies used for microarray analysis also underwent
mechanical experiments, published separately, that allowed
matching of microarray data to mechanical function [15]. Briefly,
all biopsies underwent passive mechanical testing of muscle fibers
and muscle fiber bundles. Fibers and bundles were isolated and
stretched with the result of the mechanical tests yielding a tangent
stiffness (kPa/mm sarcomere length). For fibers, this represents the
stiffness of components within the cell and for fiber bundles
includes cellular components as well as extracellular components.
Collagen concentration was also measured in fiber bundle
samples.
Correlations analysis was performed using MATLAB software
(Mathworks; Natick, MA). Each gene that was considered
significantly altered in children with CP from the analysis above
was correlated with each of the physical parameters measured.
Correlations were considered significant with p,0.05. No multiple
testing correction was used in determining genes significantly
correlated with mechanical data.
Supporting Information
Table S1 A list of each gene that was significantly
altered in CP. Gene_ID is affymetrix microarray spot ID. Ratio
is expression ratio of CP to typically developing controls. P-values
are listed for all 3 summarization algorithms used.
(XLSX)
Table S2 Significantly over-represented ontologies
from genes significantly up-regulated (A) or down
regulated (B) in CP. Category (C), Observed (O), Expected
(E), Ratio of observed over expected (R), raw p-value (rawP), and
multiple testing adjusted p-value (adjP).
(XLSX)
Table S3 List of gene families and complexes used for
Figure 3. Complexes are separated by the functional muscle
network.
(XLSX)
Table S4 Genes significantly correlated with passive
stiffness measurements on fibers and fiber bundles.
(XLSX)
Table S5 Primer pairs used for quantitative real-time
PCR analysis.
(XLSX)
Table S6 Significantly over-represented ontologies
from genes with positively or negatively significantly
correlated with fiber or bundle passive stiffness.
Category, Observed, Expected, and multiple testing adjusted p-
value (adjP).
(XLSX)
Table S7 Similarity between upper and lower extremity
transcriptional studies of skeletal muscle in ceregbral
palsy. The list of genes that are significantly regulated in the same
direction with cerebral palsy between the current study in
hamstring muscle and a previous study in wrist muscle. Only 13
genes were up-regulated in both and only 6 down regulated in
both. The 13 up-regulated genes were significantly over-repre-
sented in the 4 extracellular matrix gene ontologies listed.
(XLSX)
Acknowledgments
We would like to acknowledge the contributions of Dr. Eric Edmonds for
assistance in procuring biopsies. We would also like to thank Austin Carr
for performing the PCR experiments and Shannon Bremner for technical
assistance.
Author Contributions
Conceived and designed the experiments: LRS HGC SS RLL. Performed
the experiments: LRS HGC. Analyzed the data: LRS SS RLL.
Contributed reagents/materials/analysis tools: HGC SS. Wrote the paper:
LRS SS HGC RLL.
Muscle Transcript Abnormalities in Cerebral Palsy
PLOS ONE | www.plosone.org 11 August 2012 | Volume 7 | Issue 8 | e40686
References
1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, et al. (2007) A report:
the definition and classification of cerebral palsy April 2006. Dev Med Child
Neurol Suppl 109: 8–14.
2. Reddihough DS, Collins KJ (2003) The epidemiology and causes of cerebral
palsy. Aust J Physiother 49: 7–12.
3. Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS, Benedict RE, Kirby
RS, et al. (2008) Prevalence of cerebral palsy in 8-year-old children in three areas
of the United States in 2002: a multisite collaboration. Pediatrics 121: 547–554.
4. Kerr Graham H, Selber P (2003) Musculoskeletal aspects of cerebral palsy.
J Bone Joint Surg Br 85: 157–166.
5. Crenna P (1998) Spasticity and ‘spastic’ gait in children with cerebral palsy.
Neurosci Biobehav Rev 22: 571–578.
6. Kim WH, Park EY (2011) Causal relation between spasticity, strength, gross
motor function, and functional outcome in children with cerebral palsy: a path
analysis. Dev Med Child Neurol 53: 68–73.
7. Lin JP (2011) The contribution of spasticity to the movement disorder of cerebral
palsy using pathway analysis: does spasticity matter? Dev Med Child Neurol 53:
7–9.
8. Bache CE, Selber P, Graham HK (2003) (ii) The management of spastic
diplegia. Current Orthopaedics 17: 88–104.
9. Koman LA, Smith BP, Shilt JS (2004) Cerebral palsy. Lancet 363: 1619–1631.
10. Tilton AH (2006) Therapeutic interventions for tone abnormalities in cerebral
palsy. NeuroRx 3: 217–224.
11. Hankins GD, Speer M (2003) Defining the pathogenesis and pathophysiology of
neonatal encephalopathy and cerebral palsy. Obstet Gynecol 102: 628–636.
12. Foran JR, Steinman S, Barash I, Chambers HG, Lieber RL (2005) Structural
and mechanical alterations in spastic skeletal muscle. Dev Med Child Neurol 47:
713–717.
13. Lorentzen J, Grey MJ, Crone C, Mazevet D, Biering-Sorensen F, et al. (2010)
Distinguishing active from passive components of ankle plantar flexor stiffness in
stroke, spinal cord injury and multiple sclerosis. Clin Neurophysiol.
14. Sinkjaer T, Magnussen I (1994) Passive, intrinsic and reflex-mediated stiffness in
the ankle extensors of hemiparetic patients. Brain 117 (Pt 2): 355–363.
15. Smith LR, Lee KS, Ward SR, Chambers HG, Lieber RL (2011) Hamstring
contractures in children with spastic cerebral palsy result from a stiffer
extracellular matrix and increased in vivo sarcomere length. The Journal of
physiology 589: 2625–2639.
16. Lieber RL, Friden J (2002) Spasticity causes a fundamental rearrangement of
muscle-joint interaction. Muscle Nerve 25: 265–270.
17. Malaiya R, McNee AE, Fry NR, Eve LC, Gough M, et al. (2007) The
morphology of the medial gastrocnemius in typically developing children and
children with spastic hemiplegic cerebral palsy. J Electromyogr Kinesiol 17:
657–663.
18. Mohagheghi AA, Khan T, Meadows TH, Giannikas K, Baltzopoulos V, et al.
(2007) Differences in gastrocnemius muscle architecture between the paretic and
non-paretic legs in children with hemiplegic cerebral palsy. Clin Biomech
(Bristol, Avon) 22: 718–724.
19. Mohagheghi AA, Khan T, Meadows TH, Giannikas K, Baltzopoulos V, et al.
(2008) In vivo gastrocnemius muscle fascicle length in children with and without
diplegic cerebral palsy. Dev Med Child Neurol 50: 44–50.
20. Shortland AP, Harris CA, Gough M, Robinson RO (2002) Architecture of the
medial gastrocnemius in children with spastic diplegia. Dev Med Child Neurol
44: 158–163.
21. Elder GC, Kirk J, Stewart G, Cook K, Weir D, et al. (2003) Contributing factors
to muscle weakness in children with cerebral palsy. Dev Med Child Neurol 45:
542–550.
22. Rose J, McGill KC (2005) Neuromuscular activation and motor-unit firing
characteristics in cerebral palsy. Dev Med Child Neurol 47: 329–336.
23. Stackhouse SK, Binder-Macleod SA, Lee SC (2005) Voluntary muscle
activation, contractile properties, and fatigability in children with and without
cerebral palsy. Muscle Nerve 31: 594–601.
24. Smith LR, Ponten E, Hedstrom Y, Ward SR, Chambers HG, et al. (2009) Novel
transcriptional profile in wrist muscles from cerebral palsy patients. BMC Med
Genomics 2: 44.
25. Feltrin E, Campanaro S, Diehl AD, Ehler E, Faulkner G, et al. (2009) Muscle
Research and Gene Ontology: New standards for improved data integration.
BMC Med Genomics 2: 6.
26. Klebanov L, Qiu X, Welle S, Yakovlev A (2007) Statistical methods and
microarray data. Nature biotechnology 25: 25–26; author reply 26–27.
27. Booth CM, Cortina-Borja MJ, Theologis TN (2001) Collagen accumulation in
muscles of children with cerebral palsy and correlation with severity of spasticity.
Developmental medicine and child neurology 43: 314–320.
28. Lieber RL, Runesson E, Einarsson F, Friden J (2003) Inferior mechanical
properties of spastic muscle bundles due to hypertrophic but compromised
extracellular matrix material. Muscle & nerve 28: 464–471.
29. Friden J, Lieber RL (2003) Spastic muscle cells are shorter and stiffer than
normal cells. Muscle & nerve 27: 157–164.
30. Barrett RS, Lichtwark GA (2010) Gross muscle morphology and structure in
spastic cerebral palsy: a systematic review. Developmental medicine and child
neurology 52: 794–804.
31. Theroux MC, Akins RE, Barone C, Boyce B, Miller F, et al. (2002)
Neuromuscular junctions in cerebral palsy: presence of extrajunctional
acetylcholine receptors. Anesthesiology 96: 330–335.
32. Tsay HJ, Schmidt J (1989) Skeletal muscle denervation activates acetylcholine
receptor genes. The Journal of cell biology 108: 1523–1526.
33. Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P (2006) Pharmacotherapy
of spasticity in children with cerebral palsy. Pediatric neurology 34: 1–6.
34. Schiaffino S, Reggiani C (1996) Molecular diversity of myofibrillar proteins:
gene regulation and functional significance. Physiological reviews 76: 371–423.
35. Olive M, Shatunov A, Gonzalez L, Carmona O, Moreno D, et al. (2008)
Transcription-terminating mutation in telethonin causing autosomal recessive
muscular dystrophy type 2G in a European patient. Neuromuscular disorders :
NMD 18: 929–933.
36. Brown CA, Scharner J, Felice K, Meriggioli MN, Tarnopolsky M, et al. (2011)
Novel and recurrent EMD mutations in patients with Emery-Dreifuss muscular
dystrophy, identify exon 2 as a mutation hot spot. Journal of human genetics.
37. Maraldi NM, Capanni C, Del Coco R, Squarzoni S, Columbaro M, et al. (2011)
Muscular laminopathies: role of prelamin A in early steps of muscle
differentiation. Advances in enzyme regulation 51: 246–256.
38. Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, et al. (2007) Relationships between
transforming growth factor-beta1, myostatin, and decorin: implications for
skeletal muscle fibrosis. The Journal of biological chemistry 282: 25852–25863.
39. Ivanhoe CB, Reistetter TA (2004) Spasticity: the misunderstood part of the
upper motor neuron syndrome. American journal of physical medicine &
rehabilitation/Association of Academic Physiatrists 83: S3–9.
40. Pohl M, Mehrholz J, Rockstroh G, Ruckriem S, Koch R (2007) Contractures
and involuntary muscle overactivity in severe brain injury. Brain injury : [BI] 21:
421–432.
41. Smith C, Kruger MJ, Smith RM, Myburgh KH (2008) The inflammatory
response to skeletal muscle injury: illuminating complexities. Sports medicine 38:
947–969.
42. Tardieu C, Huet de la Tour E, Bret MD, Tardieu G (1982) Muscle
hypoextensibility in children with cerebral palsy: I. Clinical and experimental
observations. Archives of physical medicine and rehabilitation 63: 97–102.
43. Tardieu G, Tardieu C, Colbeau-Justin P, Lespargot A (1982) Muscle
hypoextensibility in children with cerebral palsy: II. Therapeutic implications.
Archives of physical medicine and rehabilitation 63: 103–107.
44. Clavet H, Hebert PC, Fergusson D, Doucette S, Trudel G (2008) Joint
contracture following prolonged stay in the intensive care unit. CMAJ :
Canadian Medical Association journal = journal de l’Association medicale
canadienne 178: 691–697.
45. Husmann I, Soulet L, Gautron J, Martelly I, Barritault D (1996) Growth factors
in skeletal muscle regeneration. Cytokine & growth factor reviews 7: 249–258.
46. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, et al. (2004) Foxo
transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and
cause skeletal muscle atrophy. Cell 117: 399–412.
47. Ponten EM, Stal PS (2007) Decreased capillarization and a shift to fast myosin
heavy chain IIx in the biceps brachii muscle from young adults with spastic
paresis. Journal of the neurological sciences 253: 25–33.
48. Scelsi R, Lotta S, Lommi G, Poggi P, Marchetti C (1984) Hemiplegic atrophy.
Morphological findings in the anterior tibial muscle of patients with cerebral
vascular accidents. Acta neuropathologica 62: 324–331.
49. Neagoe C, Opitz CA, Makarenko I, Linke WA (2003) Gigantic variety:
expression patterns of titin isoforms in striated muscles and consequences for
myofibrillar passive stiffness. Journal of muscle research and cell motility 24:
175–189.
50. Ducomps C, Mauriege P, Darche B, Combes S, Lebas F, et al. (2003) Effects of
jump training on passive mechanical stress and stiffness in rabbit skeletal muscle:
role of collagen. Acta physiologica Scandinavica 178: 215–224.
51. Mrosek M, Labeit D, Witt S, Heerklotz H, von Castelmur E, et al. (2007)
Molecular determinants for the recruitment of the ubiquitin-ligase MuRF-1 onto
M-line titin. The FASEB journal : official publication of the Federation of
American Societies for Experimental Biology 21: 1383–1392.
52. Kovanen V (2002) Intramuscular extracellular matrix: complex environment of
muscle cells. Exercise and sport sciences reviews 30: 20–25.
53. Dzienkowski RC, Smith KK, Dillow KA, Yucha CB (1996) Cerebral palsy: a
comprehensive review. The Nurse practitioner 21: 45–48, 51–44, 57–49; quiz
60–41.
54. Boonen KJ, Rosaria-Chak KY, Baaijens FP, van der Schaft DW, Post MJ (2009)
Essential environmental cues from the satellite cell niche: optimizing
proliferation and differentiation. American journal of physiology Cell physiology
296: C1338–1345.
55. Gilbert PM, Havenstrite KL, Magnusson KE, Sacco A, Leonardi NA, et al.
(2010) Substrate elasticity regulates skeletal muscle stem cell self-renewal in
culture. Science 329: 1078–1081.
56. Chen X, Li Y (2009) Role of matrix metalloproteinases in skeletal muscle:
migration, differentiation, regeneration and fibrosis. Cell adhesion & migration
3: 337–341.
57. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, et al. (1997)
Development and reliability of a system to classify gross motor function in
children with cerebral palsy. Dev Med Child Neurol 39: 214–223.
Muscle Transcript Abnormalities in Cerebral Palsy
PLOS ONE | www.plosone.org 12 August 2012 | Volume 7 | Issue 8 | e40686
58. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for
exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741–
748.
59. Zhang B, Schmoyer D, Kirov S, Snoddy J (2004) GOTree Machine (GOTM): a
web-based platform for interpreting sets of interesting genes using Gene
Ontology hierarchies. BMC Bioinformatics 5: 16.
60. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, et al. (2007)
Integration of biological networks and gene expression data using Cytoscape.
Nat Protoc 2: 2366–2382.
Muscle Transcript Abnormalities in Cerebral Palsy
PLOS ONE | www.plosone.org 13 August 2012 | Volume 7 | Issue 8 | e40686
